home / stock / halb / halb news

HALB News and Press, Tykhe Corp From 12/15/21

Stock Information
Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com
Menu
HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...
HALB - Halberd Eradicates Another Inflammatory Cytokine, Interleukin-12, In Its Continuing Effort To Eliminate Neurodegenerative Diseases

JACKSON CENTER, PA / ACCESSWIRE / December 15, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-12 (IL-12) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Interleukin-12 is a pro-inflammatory cytokine which has recently been ide...
HALB - Halberd Successfully Eradicates Interleukin-1 in Its Continued Progress Toward Eliminating Neurodegenerative Diseases

JACKSON CENTER, PA / ACCESSWIRE / December 13, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-1 (IL-1) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Interleukin-1 is associated with numerous diseases ranging from autoimmune ...

HALB - Halberd Successfully Eradicates Interluekin-1 in Its Continued Progress Toward Eliminating Neurodegenerative Diseases

Jackson Center, Pennsylvania--(Newsfile Corp. - December 13, 2021) - Halberd Corporation (OTC Pink: HALB) has demonstrated 100% eradication of Interleukin-1 (IL-1) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Interleukin-1 is associated with numerous diseases ranging from...

HALB - Halberd Follow-Up Verification Tests Prove 100% Eradication of TNF-alpha, a Major Contributing Factor to Alzheimer's Disease and PTSD/CTE

Jackson Center, Pennsylvania--(Newsfile Corp. - December 6, 2021) - Halberd Corporation (OTC PINK: HALB) completed verification tests on elimination of Tumor Necrosis Factor-alpha (TNF-alpha) from synthetic cerebral spinal fluid (CSF). These tests confirmed virtually 100% elimination of T...
HALB - Halberd Follow-up Verification Tests Prove 100% Eradication of TNF-alpha, a Major Contributing Factor to Alzheimer's Disease and PTSD/CTE

JACKSON CENTER, PA / ACCESSWIRE / December 6, 2021 / Halberd Corporation (OTC PINK:HALB) completed verification tests on elimination of Tumor Necrosis Factor-alpha (TNF-alpha) from synthetic cerebral spinal fluid (CSF). These tests confirmed virtually 100% elimination of TNF-alpha through ...

HALB - Halberd Successfully Eradicates TNF-a, a Major Contributing Factor to Alzheimer's Disease

JACKSON CENTER, PA / ACCESSWIRE / November 22, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 85% of Tumor Necrosis Factor-alpha (TNF-α) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Through Halberd's patented extracorporeal process, in combi...

HALB - Halberd Successfully Eradicates TNF-alpha, Major Contributing Factor to Alzheimer's Disease

Jackson Center, Pennsylvania--(Newsfile Corp. - November 22, 2021) - Halberd Corporation (OTC Pink: HALB) successfully eradicated 85% of Tumor Necrosis Factor-alpha (TNF-α) from synthetic cerebral spinal fluid (CSF) in preliminary testing. Through Halberd's patented extracorporeal proce...
HALB - Halberd Files Additional Extracorporeal Patent Application: Treatment of Covid-19 By Exposure to Tuned Radio Frequency Waves

Jackson Center, Pennsylvania--(Newsfile Corp. - November 8, 2021) - Halberd Corporation (OTC Pink: HALB) filed a non-provisional patent application for the extracorporeal treatment of Covid-19 through exposure to radio frequency waves. Previously, Halberd filed a provisional patent application...

HALB - GTX Corp Begins Selling Vita-Shield-Max Immune Support Nutraceutical

LOS ANGELES CALIFORNIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“the Company”) , a pioneer in the fields of: health & safety wearable GPS human and asset tracking systems and personal protective medical equipment and supplies, today anno...

HALB - Halberd Successfully Eradicates IL-6, a Critical Factor in PTSD, CTE & Alzheimer's Disease

Elevated levels of IL-6 are believed to be causal factors in PTSD, Chronic Traumatic Encephalopathy, & Alzheimer's Disease. JACKSON CENTER, PA / ACCESSWIRE / November 1, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 100% of IL-6 from synthetic cerebral spinal ...
Previous 10 Next 10